Indamid Sr

Indapamide, the active ingredient in Indamid Sr, is a thiazide‑like diuretic presented as an oral dosage form for systemic use. It is employed to lower elevated blood pressure and to reduce fluid accumulation in conditions such as heart failure‑related edema and renal disease‑associated edema.

GNH USA supplies Indamid Sr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent product quality across multiple markets, and adhering to stringent quality standards.

Indapamide is used to manage conditions related to fluid overload and elevated blood pressure. Hypertension: helps lower systemic arterial pressure and reduce cardiovascular risk. Edema associated with heart failure: promotes diuresis to decrease fluid accumulation and relieve symptoms. Edema due to renal disease: facilitates removal of excess fluid in patients with renal impairment.

Indapamide may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness or light‑headedness - Headache - Electrolyte disturbances (e.g., low potassium or sodium) - Increased uric acid levels - Elevated blood glucose - Photosensitivity or mild skin rash

Serious or Rare Side Effects: - Severe electrolyte imbalance leading to cardiac arrhythmia - Acute renal failure or significant rise in creatinine - Severe hypersensitivity reactions such as angioedema or anaphylaxis - Pancreatitis - Marked hypotension causing fainting or shock

When prescribing indapamide, clinicians should consider several safety measures. Monitor electrolytes: check serum potassium, sodium and uric acid regularly. Assess renal function: evaluate creatinine and eGFR before and during therapy. Avoid abrupt discontinuation: taper dose to prevent rebound hypertension. Caution in diabetes: monitor blood glucose as thiazide may raise glucose levels. Pregnancy and lactation: use only if clearly needed, as safety data are limited. Store at ambient temperature: keep below 25 °C, protect from moisture and light in original container.

Indapamide can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Lithium: increased risk of lithium toxicity. - Ciclosporin: may enhance nephrotoxic effects. - Potassium‑sparing diuretics: risk of hyperkalemia. - ACE inhibitors or ARBs: may cause excessive potassium rise. - Other antihypertensives: additive blood‑pressure lowering effect.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce diuretic efficacy and affect renal function. - Digitalis glycosides: increased risk of arrhythmia due to electrolyte shifts. - Antidiabetic agents: potential for enhanced hypoglycaemia. - Corticosteroids: may exacerbate electrolyte loss. - Antihyperuricemic drugs: may require dose adjustment for uric acid control.